ANSTO Publications Online >
Journal Publications >
Journal Articles >

Please use this identifier to cite or link to this item: http://apo.ansto.gov.au/dspace/handle/10238/9299

Title: Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma
Authors: Liu, X
Pham, TQ
Berghofer, PJ
Chapman, J
Greguric, I
Mitchell, P
Mattner, F
Loc'h, C
Katsifis, A
Keywords: Synthesis
Iodine 123
Melanomas
Neoplams
single photon emision computed tomography
Laboratory animals
Issue Date: 1-Oct-2008
Publisher: Elsevier B.V.
Citation: Liu, X., Pham, T. Q., Berghofer, P., Chapman, J., Greguric, I., Mitchell, P., Mattner, F., Loc'h, C., & Katsifis, A. (2008). Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma. Nuclear Medicine and Biology, 35(7), 769-781. doi.org/10.1016/j.nucmedbio.2008.05.011
Abstract: Introduction A series of iodonicotinamides based on the melanin-binding iodobenzamide compound N-2-diethylaminoethyl-4-iodobenzamide was prepared and evaluated for the potential imaging and staging of disseminated metastatic melanoma. Methods [123I]Iodonicotinamides were prepared by iododestannylation reactions using no-carrier-added iodine-123 and evaluated in vivo by biodistribution and competition studies and by single photon emission computed tomography (SPECT) imaging in black and albino nude mice bearing B16F0 murine melanotic and A375 human amelanotic melanoma tumours, respectively. Results The iodonicotinamides displayed low-affinity binding for σ1–σ2 receptors (Ki>300 nM). In biodistribution studies in mice, N-(2-(diethylamino)ethyl)-5-[123I]iodonicotinamide ([123I]1) exhibited the fastest and highest uptake of the nicotinamide series in the B16F0 tumour at 1 h (∼8% ID/g), decreasing slowly over time. No uptake was observed in the A375 tumour. Clearance from the animals by urinary excretion was more rapid for N-alkyl-nicotinamides than for piperazinyl derivatives. At 1 h postinjection, the urinary excretion was 66% ID for [123I]1, while the gastrointestinal tract amounted to 17% ID. Haloperidol was unable to reduce the uptake of [123I]1 in pigmented mice, indicating that this uptake was likely due to an interaction with melanin. SPECT imaging of [123I]1 in black mice bearing the B16F0 melanoma indicated that the radioactivity was predominately located in the tumour and eyes. No specific localisation was observed in nude mice bearing A375 amelanotic tumours. Conclusion These findings suggest that [123I]1, which displays high tumour uptake with rapid clearance from the body, could be a promising imaging agent for the detection of melanotic tumours. © 2008 Elsevier Inc.
URI: https://doi.org/10.1016/j.nucmedbio.2008.05.011
http://apo.ansto.gov.au/dspace/handle/10238/9299
ISSN: 0969-8051
Appears in Collections:Journal Articles

Files in This Item:

There are no files associated with this item.

Items in APO are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback